amfAR, The Foundation for AIDS Research
amfAR’s public policy office in Washington, D.C., educates policy makers, the media, and the public about evidence-based policies to address HIV/AIDS in the U.S. and around the world.
A new amfAR report demonstrates that vigilance is needed to sustain the global fight against HIV, even if a cure is found.
amfAR infographic illustrates the advances on global HIV/AIDS made possible by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).
A new amfAR/TREAT Asia report advocates expanded access to vaccines that prevent HPV, the cause of cervical cancer.
amfAR report spells out recommendations for health plans and health care purchasers
The broad benefits of increased investment in HIV/AIDS research
New database enables users to access and understand PEPFAR programs and priorities at a deeper level than was previously possible.
amfAR’s issue briefs and short films make a convincing case for ending the ban on federal funding for syringe services programs.
An amfAR research team recently evaluated the extent to which PEPFAR funds were allocated to programs targeting populations at highest risk.
The broad benefits of increased investments in HIV/AIDS research
Absent this enormously successful program, the world would be a remarkably different place.
© 2017 amfAR All Rights Reserved